publication . Article . 2010

Circulation of human influenza viruses and emergence of Oseltamivir-resistant A(H1N1) viruses in Cameroon, Central Africa

Richard Njouom; Serge Alain Sadeuh; Dominique Noah Noah; Victoria Gregory; Patrick J. Collins; Pierre Cappy; Alan Hay; Dominique Rousset;
Open Access
  • Published: 01 Mar 2010
  • Publisher: Springer Nature
<p>Abstract</p> <p>Background</p> <p>While influenza surveillance has increased in most developing countries in the last few years, little influenza surveillance has been carried out in sub-Saharan Africa and no information is available in Central Africa. The objective of this study was to assess the prevalence of influenza viruses circulating in Yaounde, Cameroon and determine their antigenic and genetic characteristics.</p> <p>Methods</p> <p>Throat and/or nasal swabs were collected from November 2007 to October 2008 from outpatients with influenza-like illness (ILI) in Yaounde, Cameroon and analyzed by two different techniques: a one-step real time reverse tra...
Persistent Identifiers
Medical Subject Headings: virus diseasesviruses
free text keywords: MESH: Adolescent, MESH: Adult, MESH: Child, Preschool, MESH: Dogs, MESH: Drug Resistance, Viral, MESH: Female, MESH: Hemagglutination Inhibition Tests, MESH: Humans, MESH: Infant, MESH: Influenza, Human, MESH: Male, MESH: Middle Aged, MESH: Aged, MESH: Nose, MESH: Orthomyxoviridae, MESH: Oseltamivir, MESH: Pharynx, MESH: Prevalence, MESH: RNA, Viral, MESH: Reverse Transcriptase Polymerase Chain Reaction, MESH: Young Adult, MESH: Aged, 80 and over, MESH: Amino Acid Substitution, MESH: Animals, MESH: Antiviral Agents, MESH: Cameroon, MESH: Cell Line, MESH: Child, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, Research Article, Infectious Diseases, lcsh:Infectious and parasitic diseases, lcsh:RC109-216, Oseltamivir, chemistry.chemical_compound, chemistry, Orthomyxoviridae, biology.organism_classification, biology, Parasitology, Medical microbiology, medicine.medical_specialty, medicine, Oseltamivir resistant, Central africa, Zanamivir, medicine.drug, Virology, Influenza A virus subtype H5N1, medicine.disease_cause
16 references, page 1 of 2

1. Glezen WP: Emerging infections: pandemic influenza. Epidemiol Rev 1996, 18(1):64-76. [OpenAIRE]

2. Hilleman MR: Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 2002, 20(25- 26):3068-3087. [OpenAIRE]

3. WHO: Recommended composition of influenza virus vaccines for use in the 2008-2009 influenza season. Wkly Epidemiol Rec 2008, 83(9):81-87.

4. WHO: Recommended composition of influenza virus vaccines for use in the 2009 southern hemisphere influenza season. Wkly Epidemiol Rec 2008, 83(41):366-372.

5. Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF, Senne DA, Krauss S, Shortridge KF, Webster RG: Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998, 351(9101):472-477.

6. Stohr K: The global agenda on influenza surveillance and control. Vaccine 2003, 21(16):1744-1748.

7. Akoua-Koffi C, Kouakou B, Kadjo H, Elia G, Koffi SP, Adjogoua E, Dosso M, Ehouman A: [Results of two-year surveillance of flu in Abidjan, Cote d'Ivoire]. Med Trop (Mars) 2007, 67(3):259-262.

8. Besselaar TG, Botha L, McAnerney JM, Schoub BD: Antigenic and molecular analysis of influenza A (H3N2) virus strains isolated from a localised influenza outbreak in South Africa in 2003. J Med Virol 2004, 73(1):71-78.

9. Dosseh A, Ndiaye K, Spiegel A, Sagna M, Mathiot C: Epidemiological and virological influenza survey in Dakar, Senegal: 1996-1998. Am J Trop Med Hyg 2000, 62(5):639-643.

10. Gachara G, Ngeranwa J, Magana JM, Simwa JM, Wango PW, Lifumo SM, Ochieng WO: Influenza virus strains in Nairobi, Kenya. J Clin Virol 2006, 35(1):117-118.

11. Rabarijaona LP, Rakotondrarija NT, Rousset D, Soares JL, Mauclere P: [Influenza epidemiologic and virologic surveillance in Antananarivo from 1995 to 2002]. Arch Inst Pasteur Madagascar 2003, 69(1-2):20-26.

12. Spackman E, Senne D, Myers TJ, Bulaga L, Garber L, Perdue M, Lohman K, Daum L, Suarez D: Development of a Real-Time Reverse Transcriptase PCR Assay for Type A Influenza Virus and the Avian H5 and H7 Hemagglutinin Subtypes. J Clin Microbiol 2002, 40:3256-3260.

13. Potier M, Mameli L, Belisle M, Dallaire L, Melancon SB: Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-Nacetylneuraminate) substrate. Anal Biochem 1979, 94:287-296.

14. Wetherall N, Trivedi T, Zeller J, Hodges-Savola C, McKimm-Breschkin J, Zambon M, Hayden F: Evaluation of Neuraminidase Enzyme Assays Using Different Substrates To Measure Susceptibility of Influenza Virus Clinical Isolates to Neuraminidase Inhibitors: Report of the Neuraminidase Inhibitor Susceptibility Network. J Clin Microbiol 2003, 41:742-750.

15. Meijer A, Lackenby A, Hungnes O, Lina B, Werf van der S, Schweiger B, Opp M, Paget J, Kassteele van de J, Hay A, Zambon M: Oseltamivirresistant influenza virus A(H1N1), Europe, 2007-08 season. Emerg Infect Dis 2009, 15(4):552-560. [OpenAIRE]

16 references, page 1 of 2
Any information missing or wrong?Report an Issue